The top 10 neighbors for FiercePharma span four distinct subcategories — Academics, Professionals, B2B brands, News Publishers, Magazines, and a Government Official — with no single cluster dominating and scores compressed into a narrow band from 0.94 to 0.96.

The shape is flat: Atul Gawande leads at 0.96, but Forrester (0.96), Eric Topol (0.96), and Ashish K. Jha (0.96) are effectively tied with it, and the remaining six neighbors — WSJ Health News (0.95), McKinsey Quarterly (0.95), Harvard Business Review (0.95), Deloitte Health Care (0.94), Health Affairs (0.94), and CDC Director (0.94) — trail by only fractions. The mix is telling: Academics and Professionals (Gawande, Topol, Jha) sit alongside B2B consultancies (Forrester), health-focused news publishers (WSJ Health News), policy-oriented magazines (Health Affairs, McKinsey Quarterly), and a government official. FiercePharma is itself a Website, and only one other Website appears in the top 10 — none of the neighbors share its subcategory. The audience is shaped instead by the intersection of health-sector expertise and professional business intelligence, a pairing that cuts across individual thought leaders, institutional publishers, and management consultancies simultaneously.

That cross-kind composition — clinical academics and B2B strategy brands occupying the same narrow similarity band — signals an audience that moves fluidly between medical and executive registers.